Anticancer Drugs Course
This Anticancer Drugs Course equips oncology professionals with practical knowledge on first-line EGFR TKI treatments for EGFR-mutated NSCLC. Participants will master therapy selection, toxicity management, resistance strategies, monitoring, and patient communication to deliver evidence-based care and improve patient outcomes effectively.

4 to 360h flexible workload
certificate valid in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Explore mechanisms of action, dosing schedules, toxicity profiles, prevention and management tactics, resistance mechanisms, second-line therapies, monitoring protocols, and effective communication skills for informed clinical decisions.
Elevify advantages
Develop skills
- Select optimal EGFR TKI first-line regimens based on current trial data.
- Plan resistance evaluation with imaging, re-biopsy, and liquid biopsy.
- Develop second-line plans matching resistance to targeted, chemo, or trial therapies.
- Prevent and manage EGFR TKI toxicities like rash, diarrhea, ILD, and cytopenias.
- Counsel patients clearly on treatment goals, side effects, and progression strategies.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course